Red Cat posted a wider-than-expected loss in Q3 and a huge sales miss.
The company withdrew its full-year sales and earnings guidance.
Weaker-than-expected demand for the company's drones puts Red Cat stock in a tough spot
Red Cat (NASDAQ: RCAT) reported its third-quarter results after the market closed on Nov. 16, and results were far worse than anticipated. The company posted a loss of $0.26 per share on sales of roughly $11.8 million. The company's loss per share was $0.05 higher than anticipated, and its sales missed the average analyst target by $28.9 million.
Making matters worse, the company withdrew its full-year revenue target. As a result, the company's stock has been hit with a big sell-off. Should investors be buying on the pullback following the defense-tech specialist's recent earnings report?
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Image source: Getty Images.
While Red Cat's revenue still rose roughly 22% year over year in the third quarter, the company's huge sales miss makes it hard to have confidence in the stock right now. Contracts in the defense industry can be lumpy and subject to timing shifts, but the withdrawal of the company's guidance suggests that the underperformance in Q3 isn't something that management expects to have smoothed over with its fourth-quarter results. Previously, the defense sector company had targeted sales between $150 million and $180 million for the year.
Making matters worse, the company's gross profit plunged to $65,000 from $638,000 in the prior-year period. The big gross margin decline in the quarter suggests a weaker earnings outlook in addition to the softer sales picture.
Along with its Q3 report, Red Cat's management said that funding and contract wins were arriving at a slower-than-anticipated pace and cited outcomes from the U.S.'s Drone Dominance Gauntlet II evaluations as a factor in the weaker-than-expected performance. With disappointing results for key drone products, I think investors have better defense stocks to choose from right now.
Keith Noonan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.